Tesamorelin acetate is a synthetic analog of growth hormone–releasing hormone (GHRH), used in research settings as a peptide agonist for GHRH receptor signaling and related endocrine pathway studies. It is commonly referenced in regulatory monographs as a synthetic peptide related to endogenous GHRH.